Physician profile
Varun Victor
NPI 1124638705
$3,871.81
in general payments reported to CMS, 2019-2025
11 companies · $3,486 in 2025
The $3,486 reported for 2025 was more than what 97% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $386 · 2025: $3,486.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $3,067 · Food and Beverage: $438 · Education: $367.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $3,066.78 |
| Food and Beverage | $437.73 |
| Education | $367.30 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $3,233.37 | 2025 | Symplicity G3 |
| Abbott Laboratories | $267.30 | 2024 | Ensite |
| W. L. Gore & Associates, INC. | $100.00 | 2025 | Gore-Tex Vascular Graft |
| Cook Medical LLC | $52.63 | 2025 | Zilver Ptx |
| Novo Nordisk INC | $50.00 | 2025 | Wegovy |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $50.00 | 2025 | Lifevest |
| Astrazeneca Pharmaceuticals LP | $33.19 | 2024 | Farxiga |
| Pfizer INC. | $31.90 | 2024 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $20.88 | 2024 | Jardiance |
| Sanofi-Aventis U.S. LLC | $17.29 | 2024 | |
| Janssen Pharmaceuticals, INC | $15.25 | 2024 | Xarelto |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Varun Victor listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.